Trial intelligence / Profile preview

Penicillin Prophylaxis for PANDAS

NCT00001359Phase 2Completed

Sponsor
National Institute of Mental Health
Start
Apr 1993
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) comparing Penicillin with Placebo (2 arms). Primary endpoint: Time to Relapse of Neuropsychiatric Symptoms at 6 months. Started Apr 1993; status: completed.

02

Drugs

Benzathine penicillin
03

Conditions

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)

Beyond the preview

Go deeper on NCT00001359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call